Binh Diep

Binh Diep, PhD, is a Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine. His research focuses on bacterial pathogenesis, antimicrobial drug development, and preclinical models for infectious diseases. He leads the Diep Lab, which has developed six rabbit infection models for testing novel antimicrobial therapies and vaccines against Gram-positive and Gram-negative bacteria. Recent funding includes an NIH contract (2024-2031) for preclinical models of infectious diseases.

Education: Postdoc in Microbial Pathogenesis (UCSF, 2008), PhD in Infectious Diseases and Immunity (UC Berkeley, 2005), and B.A. in Molecular Cell Biology (UC Berkeley, 2000).

Research Interests: Staphylococcus aureus and Pseudomonas aeruginosa pathogenesis, monoclonal antibody therapies, vaccine development, and preclinical efficacy testing in animal models. Key areas include acute bacterial skin infections, pneumonia, prosthetic joint infections, and septic shock.

Grants and Awards: NIH/NIAID IDIQ Contract (2024-2031), FDA grants, and awards such as the ICAAC Young Investigator Award (2010) and ASPIRE Young Investigator Award (2009).

Labs/Teams: Diep Lab at UCSF, specializing in translational microbiology and infectious disease modeling.